Affymetrix Enters Settlement Agreement with Shareholders over Derivative Suit | GenomeWeb

NEW YORK (GenomeWeb News) – Affymetrix disclosed in a filing with the US Securities and Exchange Commission today that it has entered into a settlement agreement regarding litigation with shareholders who had sued certain executives of the company for allegedly back-dating stock options and pocketing "hundreds of millions of dollars of corporate assets."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.